These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31630683)

  • 1. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial.
    Maldonado J; Gil-Campos M; Maldonado-Lobón JA; Benavides MR; Flores-Rojas K; Jaldo R; Jiménez Del Barco I; Bolívar V; Valero AD; Prados E; Peñalver I; Olivares M
    BMC Pediatr; 2019 Oct; 19(1):361. PubMed ID: 31630683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of
    Maldonado-Lobón JA; Blanco-Rojo R; Maldonado J; Ali MA; Almazán MV; Suanes-Cabello A; Callejón E; Jaldo R; Benavídes MR; Negrillo AM; Sañudo A; Rodríguez C; Bañuelos O; Fonollá J; Olivares M;
    Benef Microbes; 2021 Feb; 12(1):55-67. PubMed ID: 33350361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.
    Gil-Campos M; López MÁ; Rodriguez-Benítez MV; Romero J; Roncero I; Linares MD; Maldonado J; López-Huertas E; Berwind R; Ritzenthaler KL; Navas V; Sierra C; Sempere L; Geerlings A; Maldonado-Lobón JA; Valero AD; Lara-Villoslada F; Olivares M
    Pharmacol Res; 2012 Feb; 65(2):231-8. PubMed ID: 22155106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term safety of early consumption of Lactobacillus fermentum CECT5716: A 3-year follow-up of a randomized controlled trial.
    Maldonado-Lobón JA; Gil-Campos M; Maldonado J; López-Huertas E; Flores-Rojas K; Valero AD; Rodríguez-Benítez MV; Bañuelos O; Lara-Villoslada F; Fonollá J; Olivares M
    Pharmacol Res; 2015; 95-96():12-9. PubMed ID: 25697549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae.
    López-Huertas E
    Benef Microbes; 2015; 6(2):219-24. PubMed ID: 25519525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of
    Pastor-Villaescusa B; Hurtado JA; Gil-Campos M; Uberos J; Maldonado-Lobón JA; Díaz-Ropero MP; Bañuelos O; Fonollá J; Olivares M;
    Benef Microbes; 2020 May; 11(3):235-244. PubMed ID: 32216468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants.
    Maldonado J; Cañabate F; Sempere L; Vela F; Sánchez AR; Narbona E; López-Huertas E; Geerlings A; Valero AD; Olivares M; Lara-Villoslada F
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):55-61. PubMed ID: 21873895
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ozen M; Piloquet H; Schaubeck M
    Nutrients; 2023 May; 15(9):. PubMed ID: 37432320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain
    Alba C; Carrera M; Álvarez-Calatayud G; Arroyo R; Fernández L; Rodríguez JM
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic from human breast milk, Lactobacillus fermentum, promotes growth in animal model of chronic malnutrition.
    Poinsot P; Penhoat A; Mitchell M; Sauvinet V; Meiller L; Louche-Pélissier C; Meugnier E; Ruiz M; Schwarzer M; Michalski MC; Leulier F; Peretti N
    Pediatr Res; 2020 Sep; 88(3):374-381. PubMed ID: 32023624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial on the impact of early-life intervention with bifidobacteria on the healthy infant fecal microbiota and metabolome.
    Bazanella M; Maier TV; Clavel T; Lagkouvardos I; Lucio M; Maldonado-Gòmez MX; Autran C; Walter J; Bode L; Schmitt-Kopplin P; Haller D
    Am J Clin Nutr; 2017 Nov; 106(5):1274-1286. PubMed ID: 28877893
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactobacillus fermentum CECT5716 supplementation in rats during pregnancy and lactation affects mammary milk composition.
    Azagra-Boronat I; Tres A; Massot-Cladera M; Franch À; Castell M; Guardiola F; Pérez-Cano FJ; Rodríguez-Lagunas MJ
    J Dairy Sci; 2020 Apr; 103(4):2982-2992. PubMed ID: 32008776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Effect of
    Pastor-Villaescusa B; Blanco-Rojo R; Olivares M
    Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34208893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal Tolerance, Growth and Safety of a Partly Fermented Formula with Specific Prebiotics in Healthy Infants: A Double-Blind, Randomized, Controlled Trial.
    Rodriguez-Herrera A; Mulder K; Bouritius H; Rubio R; Muñoz A; Agosti M; Lista G; Corvaglia L; Ludwig T; Abrahamse-Berkeveld M; Perez-Navero JL
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31284424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
    Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
    Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics Prevent Hypertension in a Murine Model of Systemic Lupus Erythematosus Induced by Toll-Like Receptor 7 Activation.
    de la Visitación N; Robles-Vera I; Moleón-Moya J; Sánchez M; Jiménez R; Gómez-Guzmán M; González-Correa C; Olivares M; Toral M; Romero M; Duarte J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study.
    Weizman Z; Alsheikh A
    J Am Coll Nutr; 2006 Oct; 25(5):415-9. PubMed ID: 17031011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of a probiotic-containing infant formula supplemented with 2'-fucosyllactose: a double-blind randomized controlled trial.
    Alliet P; Vandenplas Y; Roggero P; Jespers SNJ; Peeters S; Stalens JP; Kortman GAM; Amico M; Berger B; Sprenger N; Cercamondi CI; Corsello G
    Nutr J; 2022 Feb; 21(1):11. PubMed ID: 35193609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials.
    Szajewska H; Chmielewska A
    BMC Pediatr; 2013 Nov; 13():185. PubMed ID: 24215626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.